Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01948479
Other study ID # PatonRCT02
Secondary ID
Status Not yet recruiting
Phase N/A
First received September 18, 2013
Last updated September 25, 2013
Start date January 2014
Est. completion date January 2015

Study information

Verified date September 2013
Source University of Plymouth
Contact Joanne Paton, PhD
Phone 01752 588845
Email joanne.paton@plymouth.ac.uk
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Interventional

Clinical Trial Summary

Insoles are designed to reduce increased loads and re-ulceration risk in patients with diabetes. The investigators previous research findings suggest that an instant insole solution may benefit some, but effectiveness is difficult to predict. The investigators propose a feasibility study using in-shoe pressure analysis to optimise the protective effect of insoles and footwear with the aim of reducing re-ulceration rates.

Early indications from exploratory case studies within the real world clinical setting suggest that by implementing the investigators previous published research findings the investigators can optimise effectiveness and reduce outcome variability of protective footwear and insoles provided to patients at risk of re-ulceration.

However a further randomised control trial is necessary to evaluate the effectiveness of in-shoe pressure analysis in reducing re-ulceration rates within the NHS setting. The proposed feasibility study will recruit 20 participants from the multidisaplinary diabetic foot clinic Derriford Hospital and allocate them to either 1) Routine insoles and footwear provision or 2) Routine insole and footwear provision, and temporary insole provision with optimisation. The findings from the feasibility study will inform protocol development for a larger clinical trial. The results of the feasibility study will be used to strengthen a protocol for a grant application to conduct the main RCT. A secondary output from the pilot study will be the dissemination of findings in a peer reviewed journal and at conference.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date January 2015
Est. primary completion date January 2015
Accepts healthy volunteers No
Gender Both
Age group 30 Years and older
Eligibility Inclusion Criteria:

- Participant is willing and able to give informed consent for participation in the study.

- Male or Female, aged 30 years or above

- Diagnosed with Diabetes Mellitus

- Recently healed/healing target ulcer on the weight-bearing surface of the foot

- Neuropathic (Mild to moderate DPN defined as insensitivity of a 10 g monofilament at 1-3 sites in the following locations: hallux, 1st, 3rd, and 5th metatarsal heads (Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, Lemaster JW, Mills JL Sr, Mueller MJ, Sheehan P, Wukich DK: Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008;31:1679-1685)

- Able (in the Investigators opinion) and willing to comply with all study requirements

Exclusion Criteria:

- The participant may not enter the study if ANY of the following apply: Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.

- None healing foot ulcer at another site that requires targeted off-loading.

- Unable to walk 5 metres with/without walking aid

- Peripheral vascular disease (non-re-constructible vascular disease as determined by arterial duplex and clinically assessed by a vascular consultant)

- Unwilling to wear therapeutic footwear

- Where amputation has been part of the current episode of care and includes ulceration site.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Device:
Optimised instant offloading insole


Locations

Country Name City State
United Kingdom Derriford Hospital Plymouth Devon

Sponsors (2)

Lead Sponsor Collaborator
University of Plymouth Plymouth Hospitals NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary ulcer recurrence rates 6 months
Secondary peak pressure reduction with the addition of the intervention Issue and 6 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05471687 - Evaluation of the Functional Impact of Coronary Stenoses in Diabetics by Spectral CT N/A
Recruiting NCT04353869 - Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications
Recruiting NCT05614115 - Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD Phase 1
Completed NCT04558775 - TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence
Not yet recruiting NCT03782155 - Effect of Supplementation With HMB and Glutamine in Wound Healing on Bloody Areas Phase 4
Completed NCT05994651 - The Effect of the Tidal Model in Diabetes Patients N/A
Completed NCT00256945 - Surface Roughness of a Dental Restorative Material and Biofilm Formation Phase 1
Completed NCT04288050 - Evaluation of Glycemic Profiles in Diabetic Patients on Dialysis Under Insulin Balsal-bolus Protocol, Using Freestyle Libre
Completed NCT01345500 - UCSD Take Charge Study N/A
Recruiting NCT01295385 - Contribution Of Nuclear Magnetic Resonance Imaging In The Study Of Diabetic Cardiomyopathy N/A
Completed NCT00387452 - Exercise and Cardiovascular Control During Upright Tilt in Older Adults With Type 2 Diabetes N/A

External Links